🇺🇸 FDA
Patent

US 7211432

Recombinant vector expressing multiple costimulatory molecules and uses thereof

granted A61KA61K2039/57A61K2239/31

Quick answer

US patent 7211432 (Recombinant vector expressing multiple costimulatory molecules and uses thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K2039/57, A61K2239/31, A61K2239/38, A61K35/12